This inventor holds 1 USPTO granted patent and 1 published patent application and 5 EPO patents. Top assignee: Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: György Krasznai: Innovator in Pharmaceutical Chemistry
Introduction
György Krasznai is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for the preparation of high-purity compounds. His work has implications for the production of essential medications.
Latest Patents
Krasznai holds a patent for a "Process for preparation of high-purity meloxicam and meloxicam potassium salt." This invention provides a method for producing high-purity meloxicam, which is crucial for ensuring the efficacy and safety of this medication. The process involves reacting meloxicam raw product with potassium hydroxide or potassium carbonate, resulting in high-purity meloxicam potassium salt monohydrate. This salt is then treated with mineral or organic acid to yield high-purity meloxicam.
Career Highlights
Throughout his career, Krasznai has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Egis Gyógyszergyár Nyilvánosan Muködö Részvénytársaság and Egis Gyógyszergyár Zrt. His experience in these organizations has allowed him to refine his skills and contribute to innovative pharmaceutical solutions.
Collaborations
Krasznai has collaborated with esteemed colleagues, including Tibor Mezei and Gyula Simig. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
György Krasznai's contributions to the field of pharmaceutical chemistry, particularly through his patent for high-purity meloxicam, highlight his role as an innovator. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
